HIV-1 replication in central nervous system increases over time on only protease inhibitor therapy-Reference-Cited by-同舟云学术

HIV-1 replication in central nervous system increases over time on only protease inhibitor therapy

Published:2016-07-28 Issue:6 Volume:205 Page:575-583
ISSN:0300-8584
Container-title:Medical Microbiology and Immunology
language:en
Short-container-title:Med Microbiol Immunol

Author:

Donath Maximilian, ,Wolf Timo,Stürmer Martin,Herrmann Eva,Bickel Markus,Khaykin Pavel,Göpel Siri,Gute Peter,Haberl Annette,de Leuw Philipp,Schüttfort Gundolf,Berger Annemarie,Stephan Christoph^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Microbiology (medical),Immunology,General Medicine,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00430-016-0469-7.pdf

Reference37 articles.

1. Stephan C, von Hentig N, Kourbeti I et al (2004) Saquinavir drug exposure is not impaired by the boosted double protease inhibitor combination of lopinavir/ritonavir. AIDS 18:503–508

2. Staszewski S, Babacan E, Stephan C et al (2006) The LOPSAQ Study: 48-week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy. J Antimicrob Chemother 58:1024–1030

3. Stephan C, Bartha V, Herrmann E, von Hentig N, Khaykin P, Knecht G, Gute P, Brodt HR, Stürmer M, Berger A, Bickel M (2013) Impact of HIV-1 replication on immunological evolution during long-term dual-boosted protease inhibitor therapy. Med Microbiol Immunol 202:117–124

4. Yazdanpanah Y, Fagard C, Descamps D et al (2009) High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trial. Clin Infect Dis 49:1441–1449

5. Imaz A, del Saz SV, Ribas MA et al (2009) Raltegravir, etravirine, and ritonavir-boosted darunavir: a safe and successful rescue regimen for multidrug-resistant HIV-1 infection. J Acquir Immune Defic Syndr 52:382–386

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The presence of resistance‐associated mutations in reverse transcriptase gene is associated with cerebrospinal fluid HIV‐1 escape: A multicentric retrospective analysis;Journal of Medical Virology;2023-04

2. CNS Considerations in ART Simplification Strategies;Current HIV/AIDS Reports;2021-11-05

3. Clinical Treatment Options and Randomized Clinical Trials for Neurocognitive Complications of HIV Infection: Combination Antiretroviral Therapy, Central Nervous System Penetration Effectiveness, and Adjuvants;Neurocognitive Complications of HIV-Infection;2020

4. Treatment of Central Nervous System Manifestations of HIV in the Current Era;Seminars in Neurology;2019-06

5. Incidence of symptomatic CSF viral escape in HIV infected patients receiving atazanavir/ritonavir (ATV/r)-containing ART: a tertiary care cohort in western India;Journal of NeuroVirology;2018-04-24